Regeneron Pharmaceuticals, Inc.
ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
Last updated:
Abstract:
The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.
Status:
Application
Type:
Utility
Filling date:
24 Mar 2021
Issue date:
2 Dec 2021